Application of Mechanistic Pharmacokinetic Model for the Optimization of Metformin Delayed Release Dosage Form for Intestinal Targeting

ABSTRACT

Background Metformin (MET) is a widely prescribed drug for managing Type 2 Diabetes Mellitus (T2DM). Despite the rich clinical experience and advantages, the clinical utility of MET in renal failure patients is limited because of the treatment-related side effects. A novel colon-targeted MET Delayed-Release (DR) dosage form could be a lucrative option for managing T2DM in renal failure patients. MET DR tablets have minimum systemic exposure and are believed to have the same efficacy as other formulations. Physiologically Based Pharmacokinetic (PBPK) modelling can be useful for drug product development, especially for new dosage forms for improving the safety, efficacy, and clinical applicability of off-patented generic drugs. Objectives The current study aims to develop a PBPK model for Proto-type (PT) screening of MET DR tablets. Materials and Methods MET PBPK model was developed based on the available literature data. Firstly, Intravenous (IV) and oral PBPK models of MET are developed and validated. The developed model was then used to predict the Bioavailability (BA) of PT MET DR tablets using Virtual Bioequivalence (VBE) trials. Results The relative bioavailability of the MET DR tablet was about 20% when compared with other MET formulations. The results indicate that the DR formulation could be effective for reducing the BA and systemic exposure of the drug in chronic renal failure patients. Conclusion PBPK modelling and VBE trials can successfully demonstrate the Pharmacokinetic (PK) parameters of PK formulations and the lower systemic exposure and site targeting of MET DR tablets could be useful for the management of T2DM in renal failure patients.

KEYWORDS

• Metformin
• Delayed release
• Renal failure
• PBPK
• Pharmacokinetics
• Optimization

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.58.3.109Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 58, ISSUE 3Methodology and Results Analysis of Effect and Economic Evaluations Related to Pharmaceutical Care Practice in China: A Recent ReviewChunyan Wei, Ruofei Li, Zhiang Wu, Guirong Xiao, Ming Hu · pp. 722–729Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 3Tablet Compression Optimization of Ivabradine Sustained-Release Tablet Using Full Factorial DesignKang Min Kim, Shugeng Cao, Jae Sung Pyo · pp. 730–735Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 3A Novel Targeted Nanoliposomal Atorvastatin Transdermal Patch Assisted with Solid Microneedles for Improved BioavailabilitySai Ramya Srikakulam, Jyothirmayee Devineni, Chandana Mokkapati, Yaswanth Venigalla, Aparna Pothuri, Anuhya Acchi, Sushil Sharma · pp. 736–750Original ArticleSame type: Article
• Article · VOLUME 58, ISSUE 3Design and Characterization of Timolol Loaded Gellan Gum Nanoparticles for Improved Ocular Drug DeliveryGurpreet Kandav, Anjali Kumari Lochab, Tamanna Sharma · pp. 751–759Original ArticleSame type: Article